Showing 1‐28 of 500
Expert Q&A: Partnering for Success in the Supplement Market
Capsules & Health Ingredients   |  Article
Expert Q&A: Partnering for Success in the Supplement Market
Explore how Lonza's innovative platform and visionary approach to partnership empower brands with a full menu of tailored services...
/knowledge-center/chi/nutra/dosage-form-solutions/lonza-partnering-supplement-success
Innovative AI-Driven Solutions to Address the Growing Complexity of APIs
Small Molecules   |  Webinar (on-demand)
Innovative AI-Driven Solutions to Address the Growing Complexity of APIs
Developing innovative medicines often involves intricate small-molecule APIs with lengthy synthetic routes. This complexity can si...
/knowledge-center/smallmolecules/w/opcu-october-2024
Charting a Successful CMC Journey for Your ADC Drug Product
Biologics   |  Webinar (on-demand)
Charting a Successful CMC Journey for Your ADC Drug Product
Bioconjugates and Antibody drug conjugates (ADCs) are revolutionizing cancer therapy with their targeted mechanism of action, offe...
/knowledge-center/biologics/w/cmc-adc-drug-product
Expert Q&A: Accelerate Your ADC Journey
Biologics   |  Interview
Expert Q&A: Accelerate Your ADC Journey
Filling the Need for Integrated Bioconjugate Solutions Antibody drug conjugates (ADCs) are revolutionizing cancer therapy with t...
/knowledge-center/biologics/i/ibex-design-adc-q-and-a
mRNA and LNP Encapsulation Capabilities at our Geleen/NL Center of Excellence
Biologics   |  Video
mRNA and LNP Encapsulation Capabilities at our Geleen/NL Center of Excellence
Discover how our team, with its impressive mRNA/LNP track record, can help you progress your project from research stages to ...
/knowledge-center/biologics/v/mrna-lnp-encapsulation-capabilities-geleen
How Emerging Biotechs can Benefit by Partnering with a CDMO for Early Stage Development
Biologics   |  Article
How Emerging Biotechs can Benefit by Partnering with a CDMO for Early Stage Development
The partnership between CDMOs and emerging biotech companies in early-stage development can be mutually beneficial. In this interv...
/knowledge-center/biologics/a/cdmo-partner-early-stage-development
6 min read
Bridging the Gaps in Oral Dosage Research: 4 Focus Areas Highlighted by the UNGAP network
Capsules & Health Ingredients   |  White paper
Bridging the Gaps in Oral Dosage Research: 4 Focus Areas Highlighted by the UNGAP network
As our designated center of excellence for novel drug delivery systems, Innovaform™ Accelerator is where we help our customers tac...
/knowledge-center/chi/pharma/services/oral-dosage-research
CAR-T Cells on the Fast Lane: From T-cell Selection to CAR-T Cell Drug Product in Just 3 Days
Cell & Gene   |  Video
CAR-T Cells on the Fast Lane: From T-cell Selection to CAR-T Cell Drug Product in Just 3 Days
In this presentation, we explore the rapid growth of the CAR T market, driven by oncology advancements and innovative clinical app...
/knowledge-center/cellgene/v/car-tcr24-cocoon
Unlocking the Potential of Carrier-Based Formulations: A Process Optimization Guide
Small Molecules   |  White paper
Unlocking the Potential of Carrier-Based Formulations: A Process Optimization Guide
Carrier-based formulations are commonly used in drug delivery systems, particularly in inhalation therapies. These formulations in...
/knowledge-center/smallmolecules/es/beyond-jet-milling-paper
Early Preclinical Development of mRNA/LNP Projects, Transitioning Successfully to cGMP Manufacturing
Biologics   |  Webinar (on-demand)
Early Preclinical Development of mRNA/LNP Projects, Transitioning Successfully to cGMP Manufacturing
View our on-demand webinar exploring the development steps that lead to an mRNA construct optimized for your requirements and futu...
/knowledge-center/biologics/w/early-preclinical-development-mrna-lnp
Enhanced GS® CHO Vector Technology for Improved Expression Control of Biotherapeutic Proteins
Biologics   |  Webinar (on-demand)
Enhanced GS® CHO Vector Technology for Improved Expression Control of Biotherapeutic Proteins
Many of today’s expression platforms for recombinant protein production have been optimised for the expression of monoclonal antib...
/knowledge-center/biologics/w/tli-gs-expression-control-of-biotherapeutic-proteins
Small Molecule API & HPAPI Development Capacity
Small Molecules   |  Video
Small Molecule API & HPAPI Development Capacity
This video presents Lonza's capabilities, facility locations, and timelines to assist biopharma companies in identifying suitable ...
/knowledge-center/smallmolecules/w/small-molecule-api-hpapi-development
Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug Products
Small Molecules   |  Webinar (on-demand)
Linking Rational Design and Material-Sparing Strategies for Enabled Intermediates and Their Drug Products
The rapid development of enabled forms and formulations is crucial for tackling the challenges posed by poorly soluble molecules. ...
/knowledge-center/smallmolecules/w/linking-rational-design
Pioneering Capsule Innovation: Accelerating Oral and Inhalable Drug Delivery
Capsules & Health Ingredients   |  Presentation (on-demand)
Pioneering Capsule Innovation: Accelerating Oral and Inhalable Drug Delivery
Watch Dr. Camille Dumont and Meeta Kratz's presentation at CPHI Worldwide 2024. Explore Lonza’s Innovaform™ new innovation center,...
/knowledge-center/chi/pharma/services/innovaform-drug-delivery-presentation
Transforming drug delivery through advanced capsule innovation
Capsules & Health Ingredients   |  R&D Blog post
Transforming drug delivery through advanced capsule innovation
Capsules represent one of the oldest pharmaceutical dosage forms, with a history dating back to ancient Egypt. Despite being known...
/knowledge-center/Blogs/advanced-capsule-innovation
5 min read
Integrating a High Sensitivity Immunopeptidomics (MAPPs) Assay in Preclinical Immunogenicity Risk Assessment
Biologics   |  Webinar (on-demand)
Integrating a High Sensitivity Immunopeptidomics (MAPPs) Assay in Preclinical Immunogenicity Risk Assessment
Immunogenicity poses a critical risk to all biologics, including monoclonal antibodies, ADCs, recombinant proteins, cell & gene th...
/knowledge-center/biologics/w/mapps-assay-preclinical-immunogenicity-risk-assessment
Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development and Manufacturing to Ensure Drug Quality
Biologics   |  Webinar (on-demand)
Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development and Manufacturing to Ensure Drug Quality
This on-demand webinar explores the essential alignment between regulatory affairs, process development, and manufacturing in biop...
/knowledge-center/biologics/w/navigating-biopharma-ensure-drug-quality
Considerations for Successful Tech Transfer of a Biologics Upstream Process
Biologics   |  Article
Considerations for Successful Tech Transfer of a Biologics Upstream Process
In this European Pharmaceutical Review article, bioprocess experts from Lonza discuss how molecular format and the product lifecyc...
/knowledge-center/biologics/a/tech-transfer-considerations
6 min read
Excipients for Respiratory Delivery of Biologics
Small Molecules   |  Webinar (on-demand)
Excipients for Respiratory Delivery of Biologics
Local administration of biologic Active Pharmaceutical Ingredients to the lung via inhalation has grown in recent years. Dry and l...
/knowledge-center/smallmolecules/w/excipients-respiratory-delivery-biologics
Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development
Small Molecules   |  White paper
Optimizing Spray-Dried Dispersion Processes Through Risk-Based Development
This executive summary explores a risk-based approach to process qualification, demonstrating how small-scale experiments can miti...
/knowledge-center/smallmolecules/es/optimizing-spray-dried-dispersion-processes
10 min read
Responsible Sourcing and Manufacturing: Growing Towards a Sustainable Future with Lonza
Capsules & Health Ingredients   |  Interview
Responsible Sourcing and Manufacturing: Growing Towards a Sustainable Future with Lonza
In this article Christine Lebeault, Head of Applied Sustainability, Lonza Capsules & Health Ingredients, gives her perspective on ...
/knowledge-center/chi/Sustainability/responsible-sourcing-and-manufacturing
Capsugel® in-stock vegan capsule program – EMEA
Capsules & Health Ingredients   |  Brochure
Capsugel® in-stock vegan capsule program – EMEA
Select from a variety of vegan options to satisfy your market needs quickly. Experience the many benefits of choosing from our in-...
/knowledge-center/chi/nutra/capsules/capsugel-instock-vegan-capsule-program
Unlocking Pet Joint Health with Collagen - Webinar
Capsules & Health Ingredients   |  Webinar (on-demand)
Unlocking Pet Joint Health with Collagen - Webinar
Walking, running, playing, jumping. In this webinar, learn how you can support active owners’ companions too with Lonza’s UC-II® u...
/knowledge-center/chi/nutra/ingredients/ucii-pets-webinar
From Technology Selection to Final Drug Product
Small Molecules   |  White paper
From Technology Selection to Final Drug Product
Many new active pharmaceutical ingredients (APIs) suffer from poor gastro-intestinal solubility in their crystalline form. This lo...
/knowledge-center/smallmolecules/es/material-sparing-approaches-for-asd-development
Dry Powder Vaccines to Improve Global Access and Pandemic Response
Small Molecules   |  White paper
Dry Powder Vaccines to Improve Global Access and Pandemic Response
Many vaccines require cold chain storage and distribution, limiting their accessibility in resource-poor regions. Dry powder formu...
/knowledge-center/smallmolecules/es/dry-powder-vaccines
15 min read
Micro-dosing: Navigating the Path from Development to Commercialization with Powder-in-Capsule Technology
Small Molecules   |  White paper
Micro-dosing: Navigating the Path from Development to Commercialization with Powder-in-Capsule Technology
Microdosing, a technique involving the administration of precise, minimal drug doses, can significantly accelerate the drug devel...
/knowledge-center/smallmolecules/es/micro-dosing-powder-in-capsule-technology
15 min read
Support the new era of active lifestyle consumers
Capsules & Health Ingredients   |  e-book
Support the new era of active lifestyle consumers
The joint health market is expanding to include a new wave of younger consumers who understand that mobility is inextricably linke...
/knowledge-center/chi/nutra/ingredients/ucii-collagen-active-lifestyle-ebook
UC-II® for Pets: Science Summary
Capsules & Health Ingredients   |  Infographic
UC-II® for Pets: Science Summary
Lonza’s UC-II® undenatured type II collagen is supported by a comprehensive body of brand specific evidence-based research spannin...
/knowledge-center/chi/nutra/ingredients/ucii-pets-science-summary
1 2 3 4 ... 18 >
Meet our experts

Our community is composed of technical experts who have decades of experience in a range of topics and project challenges.

View all experts
Meet our Biologics experts
Meet our Small Molecules experts